Skip to main content

Cassie

Analyst

RBC Capital Markets

Equibles does not estimate personal net worth.

About Cassie

Cassie is recorded as Analyst at RBC Capital Markets. Cassie has spoken on 2 earnings calls across 2 companies, most recently for Allogene Therapeutics, Inc. on August 12, 2026. Those appearances were for Allogene Therapeutics, Inc. (ALLO) and Arrowhead Pharmaceuticals, Inc. (ARWR). The companies whose calls Cassie spoke on are classified in the Healthcare sector.

Cassie on recent calls

“Just a question on the 329 trial with the data coming in fourth quarter. Just wondering if your guidance has changed in terms of the dose groups that you're going to announce.”
Analyst — RBC Capital Markets, The Allogene Therapeutics Second Quarter 2026 Conference Call ·
“A question also on NKB and AUG 7, since we just talked about the regulatory path. Andy, I appreciate early days, but how are you thinking about potential pricing for NKB and AUG 7?”
Analyst — RBC Capital Markets, Arrowhead Pharmaceuticals, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • RBC Capital Markets

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity